Literature DB >> 28579578

The T-Box transcription factor 3 in development and cancer.

Tarryn Willmer1, Aretha Cooper1, Jade Peres1, Rehana Omar1, Sharon Prince1.   

Abstract

T-box factors comprise an archaic family of evolutionary conserved transcription factors that regulate patterns of gene expression essential for embryonic development. The T-box transcription factor 3 (TBX3), a member of this family, is expressed in several tissues and plays critical roles in, among other structures, the heart, mammary gland and limbs and haploinsufficiency of the human TBX3 gene is the genetic basis for the autosomal dominant disorder, ulnar-mammary syndrome. Overexpression of TBX3 on the other hand has been linked to several cancers including melanoma, breast, pancreatic, liver, lung, head and neck, ovarian, bladder carcinomas and a number of sarcoma subtypes. Furthermore, there is strong evidence that TBX3 promotes oncogenesis by impacting proliferation, tumour formation, metastasis as well as cell survival and drug resistance. More recently, TBX3 was however shown to also have tumour suppressor activity in fibrosarcomas and thus its functions in oncogenesis appear to be context dependent. Identification of the upstream regulators of TBX3 and the molecular mechanism(s) underpinning its oncogenic roles will make valuable contributions to cancer biology.

Entities:  

Keywords:  TBX3; embryogenesis; oncogenesis; transcription factor

Mesh:

Substances:

Year:  2017        PMID: 28579578     DOI: 10.5582/bst.2017.01043

Source DB:  PubMed          Journal:  Biosci Trends        ISSN: 1881-7815            Impact factor:   2.400


  11 in total

Review 1.  The roles and regulation of TBX3 in development and disease.

Authors:  Saif F Khan; Victoria Damerell; Rehana Omar; Michelle Du Toit; Mohsin Khan; Hapiloe Mabaruti Maranyane; Mihlali Mlaza; Jenna Bleloch; Claire Bellis; Bianca D B Sahm; Jade Peres; K N ArulJothi; Sharon Prince
Journal:  Gene       Date:  2019-10-26       Impact factor: 3.688

2.  TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.

Authors:  Binyong Liang; Yi Zhou; Manning Qian; Meng Xu; Jingxiao Wang; Yi Zhang; Xinhua Song; Haichuan Wang; Shumei Lin; Chuanli Ren; Satdarshan P Monga; Bruce Wang; Matthias Evert; Yifa Chen; Xiaoping Chen; Zhiyong Huang; Diego F Calvisi; Xin Chen
Journal:  J Hepatol       Date:  2021-02-10       Impact factor: 30.083

3.  Transcription box‑3 protects human umbilical vein endothelial cells in a high‑glucose environment through sirtuin 1/AKT signaling.

Authors:  Zhanjiang Yu; Wei Zhang; Xiankun Zhang; Donghui Xu; Na Wang
Journal:  Mol Med Rep       Date:  2020-06-15       Impact factor: 2.952

4.  TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.

Authors:  Milica Krstic; Bart Kolendowski; Matthew J Cecchini; Carl O Postenka; Haider M Hassan; Joseph Andrews; Connor D MacMillan; Karla C Williams; Hon S Leong; Muriel Brackstone; Joseph Torchia; Ann F Chambers; Alan B Tuck
Journal:  J Pathol       Date:  2019-04-08       Impact factor: 7.996

5.  Chromatin interactome mapping at 139 independent breast cancer risk signals.

Authors:  Jonathan Beesley; Haran Sivakumaran; Mahdi Moradi Marjaneh; Luize G Lima; Kristine M Hillman; Susanne Kaufmann; Natasha Tuano; Nehal Hussein; Sunyoung Ham; Pamela Mukhopadhyay; Stephen Kazakoff; Jason S Lee; Kyriaki Michailidou; Daniel R Barnes; Antonis C Antoniou; Laura Fachal; Alison M Dunning; Douglas F Easton; Nicola Waddell; Joseph Rosenbluh; Andreas Möller; Georgia Chenevix-Trench; Juliet D French; Stacey L Edwards
Journal:  Genome Biol       Date:  2020-01-07       Impact factor: 13.583

Review 6.  Signaling pathways governing breast cancer stem cells behavior.

Authors:  Kai Song; Maryam Farzaneh
Journal:  Stem Cell Res Ther       Date:  2021-04-16       Impact factor: 6.832

7.  Establishment of the TBX-code reveals aberrantly activated T-box gene TBX3 in Hodgkin lymphoma.

Authors:  Stefan Nagel; Corinna Meyer
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

8.  Association of T-box gene polymorphisms with the risk of Wolff-Parkinson-White syndrome in a Han Chinese population.

Authors:  Bing Han; Yongxiang Wang; Jing Zhao; Qingsu Lan; Jin Zhang; Xiaoxue Meng; Jianjian Jin; Ming Bai; Zheng Zhang
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

9.  TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex.

Authors:  Dario Zimmerli; Costanza Borrelli; Amaia Jauregi-Miguel; Simon Söderholm; Salome Brütsch; Nikolaos Doumpas; Jan Reichmuth; Fabienne Murphy-Seiler; MIchel Aguet; Konrad Basler; Andreas E Moor; Claudio Cantù
Journal:  Elife       Date:  2020-08-18       Impact factor: 8.140

10.  Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors.

Authors:  Peitao Zhang; Haixia Guan; Shukai Yuan; Huili Cheng; Jian Zheng; Zhenlei Zhang; Yifan Liu; Yang Yu; Zhaowei Meng; Xiangqian Zheng; Li Zhao
Journal:  Nat Commun       Date:  2022-03-24       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.